Introduction
Prostate cancer is one of the most frequently diagnosed cancers in men. The incidence has increased over the last decade. In Germany, 68 000 men are diagnosed with prostate cancer every year [1] . The mean age at diagnosis is 69 years [2] . The median life-expectancy after treatment for prostate cancer is~14 years [3] . The relative 5-year survival rate of patients with prostate cancer is currently 87% [2] . Treatment for localised prostate cancer may involve prostatectomy, radiation therapy, hormonal therapy, active surveillance or watchful waiting. The treatment decision is a compromise between the expected beneficial and harmful effects. The 18-year cancer-specific survival after radical prostatectomy (RP) for low-and intermediate-risk prostate cancer is 85-94% [4, 5] . Estimated 10-year cause-specific survival in patients with radiation therapy with low-, intermediate-and high-risk prostate cancer is 93%, 88% and 80%, respectively [6] . For active surveillance the 10-and 15-year cause-specific survival rates are 98% and 94% [7] . Although it is a slow growing cancer in many cases, especially for Gleason score ≤6 [8] , the diagnosis of localised prostate cancer is a major life stressor for most men.
Communication Needs
Hence, the communication needs of patients with prostate cancer are increasingly becoming a subject of research. The psychosocial adjustment of patients with localised prostate cancer has been described in terms of e.g. emotional distress, traumatic stress symptoms, or decisional uncertainty [9] [10] [11] [12] . According to a meta-analysis, anxiety and depression prevalence rates are relatively high in patients with prostate cancer (14-27%) [13] . It has been shown that low confidence in cancer control, low self-efficacy for decision-making, low optimism, low resilience, and masculine identity threat are associated with higher emotional distress in patients with prostate cancer [14, 15] .
For information needs, highly variable needs were shown in patients with prostate cancer [16, 17] . Unmet information needs were found mainly in terms of knowledge of recurrence issues and side-effects of the illness and its treatment [18] . Unmet needs in the supportive care domains of sexuality, psychological concerns, health systems, and information are common [19, 20] . For psychological needs, fears about recurrence and concerns about the worries of relatives are priority need areas for men with prostate cancer [19, 20] . Almost a quarter of patients receiving androgen-deprivation therapy express interest in psychosocial services [21] , with interest in psychosocial services or social support groups being often associated with younger men [21, 22] .
Although most patients with prostate cancer prefer an active or collaborative role in treatment decision-making [23] , most do not use information about medical treatments comprehensively or systematically. Their processing of medical information is biased by their previous beliefs about cancer, health, and each therapy's intrinsic characteristics [24] [25] [26] . In particular, for patients' heuristic decision-making processes and the compromise between potential side-effects and expected beneficial effects of different therapeutic options, the provision of complete and unbiased information is essential [27] . In general, the provider is considered to be the most valuable source of information and support by patients with prostate cancer [28] .
Health-Related Quality of Life (HRQoL)
Apart from dealing with emotional and psychosocial challenges, many patients with localised prostate cancer have to deal with symptoms from the cancer and side-effects of its treatment. As the average life-expectancy for prostate cancer is~14 years [3] , the evaluation of HRQoL and changes in different domains of HRQoL during treatment is increasingly becoming an important issue [29] . General HRQoL is a multidimensional construct. It includes aspects of the physical, functional, social, cognitive, and emotional wellbeing that might be affected by the disease or its treatment [30] . Disease-specific HRQoL after treatment for localised prostate cancer includes side-effects impacting urinary, sexual, and bowel function. According to a recent comprehensive review of short-, intermediate-, and long-term outcomes after RP for localised prostate cancer, RP may cause significant short-term urinary incontinence, LUTS and sexual dysfunction that may impair HRQoL [29] . However, RP may also improve HRQoL via relief of LUTS in men with such symptoms before surgery [29] . Herkommer et al. [31] recently reported that over a 12-month period the HRQoL of older patients or patients with multiple comorbidities is not negatively influenced by RP. However, older patients have lower pre-and post-treatment HRQoL scores [32] . In the long term, HRQoL remains stable after RP; i.e. patients with favourable HRQoL during the first 5 years after RP maintain favourable outcomes thereafter [33] .
Study Aim
The aim of our research was to examine the association between patient-physician communication and HRQoL, in a sample of patients with localised prostate cancer undergoing RP, over the course of their treatment. In prostate cancer care, the associations between patient-physician communication and patient-reported outcomes have not yet been examined. A caring communication between provider and patient has been shown to be essential to meet patientsì nformation needs and to reduce the emotional distress of patients with cancer [34, 35] . Therefore we assume that psychosocial support by physicians is positively and significantly associated with the HRQoL functional scales indicating that better communication can improve patients functioning and wellbeing.
Patients and Methods
The ethics committee of the Bavarian State Board of Physicians approved the study. Data were collected within the HAROW (Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting) study. The study was designed to collect data of different treatment options, i.e. hormonal therapy, active surveillance, radiation, operation, watchful waiting, for newly diagnosed patients with localised prostate cancer (T1-2, N0, M0) in Germany under real-world conditions. It was a 5-year prospective, observational study. Patients were recruited via 259 study centres in Germany (86% private practice urologists). From July 2008 until July 2013, 3169 patients with newly diagnosed localised prostate cancer (≤cT2c) were recruited. For the present analysis, data of 1772 patients undergoing RP over a 3-year follow-up were analysed for reasons of comparability.
Patients completed written questionnaires, which were sent to their home addresses, indicating socio-demographic data, HRQoL, and aspects of patient-physician communication every 6 months. Their physicians added information on diagnosis, comorbidity, and treatment. HRQoL was assessed using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30) [30] . The EORTC QLQ-C30 is an established cancer-specific measure of HRQoL, which has been used in various national and international studies. The questionnaire addresses functional aspects of HRQoL and consists of 30 items that constitute one global health status score, five functional scores (physical, role, emotional, cognitive, and social functioning), and nine symptom scales/items (fatigue, nausea and vomiting, pain, dyspnoea, insomnia, appetite loss, constipation, diarrhoea, financial difficulties). For the present analysis, we focus on global health status and the functional scales as a first step in the analysis of the association between communication and HRQoL in prostate cancer care. Symptom scales will be the subject of future analyses. The instrument demonstrated good psychometric properties and clinical validity in earlier studies [30] . To asses various aspects of patient-physician communication the 'psychosocial care' instrument of the validated Cologne Patient Questionnaire (CPQ) was used [36, 37] . The CPQ is a 13-item instrument with four subscales: devotion, support, information, and shared decision-making. Agreement with all items was measured by four answer categories, ranging from totally disagree (i), rather disagree (ii), rather agree (iii), to totally agree (iv). The items have been described in prior HAROW publications [38] . As an indicator for risk of progression D'Amico risk categories were defined based on PSA level, tumour staging, and Gleason Score [39] . Comorbidities were assessed with the Charlson Comorbidity Index (CCI), which considers the number and severity of comorbidities [40, 41] . As sociodemographic characteristics age and partnership status were assessed.
HRQoL scores were calculated according to the user manual for the EORTC QLQ-C30 questionnaire resulting in linearly transformed scale and item scores ranging from 0 to 100, with higher scores representing a better HRQoL in the functional scales [30] . A sum score for each subscale of psychosocial care was obtained by summing all items of one subscale divided by the number of items [38] . Descriptive statistics were calculated for the sociodemographic and illness-related characteristics, psychosocial care, and HRQoL. Longitudinal two-level random intercept linear multilevel models for each of the five HRQoL functional scales and the global HRQoL scale as dependent variables were calculated, where time-points are level-1-units and patients are level-2-units. Longitudinal multilevel modelling was chosen to include time-invariant patient characteristics (e.g. sociodemography), as well as time-variant characteristics (e.g. psychosocial care by physicians) [42] [43] [44] . The models were estimated with full maximum likelihood [44] . Two-level models only with time included as dummy variables (null models) were fitted in order to calculate the intraclass correlation coefficient (ICC). The ICC provides an insight into the degree in which the outcome (HRQoL) varies between patients. Sociodemographic and illness-related characteristics were added to the models as dummy variables. The psychosocial-care scales were added as metric variables. Group-mean centering of the psychosocial-care scales was chosen to be able to separate the effects of psychosocial care into between-patient effects and within-patient effects, thus enabling a better interpretation of the results [45] . The four psychosocial-care scales on level 1 were group-mean centered on the patient's mean over all time-points. The psychosocialcare scales were additionally included as level-2 variables by aggregating the measurements at various time-points for each patient. Missing data were included as separate dummy variables to avoid case deletion. No imputations were performed. Descriptive analyses were performed with IBM SPSS 22.0. and HLM 7.0 was used for multilevel analyses.
Results

Descriptive Results
The study sample of 1772 patients with localised prostate cancer undergoing RP had a mean (range) age of 65 (40-100) years. Most patients were living with a partner (81.6%). Patients were equally distributed in terms of their risk profile according to D'Amico (31.0% low risk, 37.5% intermediate risk, 30 .7% high risk) and 73.1% had a CCI of zero (Table 1) .
Data on patients' HRQoL is shown in Figure 1 and Table 2 . HRQoL means vary between 71.1 (global HRQoL at T1; initiation) and 92.1 (physical functioning at T4; 1,5 years after diagnosis) on a scale from 0 to 100. Differences between the subscales remain stable with the global HRQoL subscale having the lowest scores and the physical functioning subscale having the highest scores. The patients' mean appraisal of psychosocial care by their physicians varied between 3.5 and 3.8 on a scale from 1 to 4 ( Fig. 2 [46] and Table 2 ). Differences in the baseline scores between subscales continued over time, with information having the highest scores and devotion having the lowest scores.
Longitudinal Multilevel Modelling
The ICCs of the null models showed variation in HRQoL between patients with values between 0.463 and 0.670 ( For psychosocial care and HRQoL, irrespective of the timepoints (on level 2), patients who felt well-informed by their physicians rated significantly higher on global HRQoL, whereas patients who felt better supported by their physicians generally rated significantly higher on emotional functioning. In addition, patients who felt more involved in their treatment rated significantly higher on social functioning. Variation in HRQoL over time can be explained by three of the four subscales of psychosocial care by physicians (on level 1). Increases in devotion by physicians were significantly associated with higher role functioning. Increases in support by physicians were significantly related with higher physical, emotional, cognitive and social functioning. Increases in shared decision-making showed significant relationships with higher global HRQoL and physical functioning. Changes in information giving were not significantly related to any of the HRQoL scales.
Discussion
It was the aim of our present study to examine whether patient-physician communication is associated with HRQoL over the course of treatment in a sample of patients with localised prostate cancer undergoing RP. We assumed that psychosocial care by physician is positively associated with patients' functional HRQoL.
Data on patients' HRQoL showed scores slightly increasing within 1.5 years from baseline. After that, the scores stagnated or slightly declined. Differences between subscales become evident at all time points, with the global HRQoL having the lowest scores and physical functioning having the highest scores. Emotional functioning is the only subscale increasing directly after RP, indicating a possible relief by the removal of the cancer. When compared with reference data of the age-adjusted male German population, HAROW patients undergoing RP have lower scores for role, emotional, and social functioning at the beginning of the treatment than German men without prostate cancer aged 60-69 years [46] . In the long term the scores are comparable to the reference population. HAROW patients are even doing better in global HRQoL than the reference population. The selection of patients eligible for RP in terms of low comorbidity might be a major reason for this fact. Psychosocial care by their physicians is generally rated very positively with limited variation over time. However, the scores decrease from baseline to the first 6 months. Here, patients might struggle with the side-effects of the RP [38] . The declines in role and social functioning 6 months after diagnosis might be caused by prostate cancer-specific symptoms or side-effects of the RP; i.e. urinary incontinence, LUTS or sexual dysfunction. Those symptoms and side-effects might cause decisional regret about the RP and might lead to a more critical appraisal of physicians' communication behaviour [38] . Differences in the baseline scores between subscales continued According to communication theories, the most probable explanation for such associations would be the 'cognitive pathway' linking aspects of communication to patients' outcomes [35] . This pathway would link empathetic communication via better exploration of patients' symptoms and needs, better diagnosis, individualised treatment regimens, better patients' education, and better treatment adherence with better long-term outcomes. However, in this pathway one would assume that the subscale information would be a significant determinant of HRQoL due to its educational nature. This did not apply to our present results. Here, information was, in most cases, not linked to changes in HRQoL over time. This might reflect that even in the long term, the 'affective pathway' in communication models, linking communication with affective short or intermediate outcomes, such as well-being via a feeling of acceptance, is at least as important as the 'cognitive pathway'.
Assuming that communication is a central predictor of HRQoL, the physicians' communication skills or styles do not necessarily have to be the reason for the variance in psychosocial care or the impact on HRQoL. We have to consider the subjectivity of relationships in interpreting our present data, as the 'quality of communication does not follow a linear scale' [47] , but is a complex interaction with various factors influencing the relationship between provider and patient. Yet, it cannot be excluded that patients with better HRQoL are more likely to build a trusting relationship with their physicians. This selection might have influenced the associations found in our present data, which we cannot control for due to our observational design. Another alternative reason for the associations between HRQoL and psychosocial care could be that patients with better HRQoL might assess their physicians' communication more favourable than patients with symptoms, side-effects, or distress. Additionally, patients' individual characteristics and skills might impact HRQoL, However, there are limitations of our present study that might have biased the results. The study was conducted in an observational design. Physicians were aware of being under observation, which might have influenced their communication behavior -at least in the early stage of the prostate cancer treatment close to patient enrolment. Additionally, a selection bias in terms of highly motivated physicians with good communication skills being overrepresented in our sample might have an impact on the assessment of communication. The observational design and the possible selection bias could be a reason for the high ratings in psychosocial care by the patients. A statistical limitation might be a possible multicollinearity between the subscales of psychosocial care, which might have contributed to the non-significance of the association between the information subscale and HRQoL, as information is a substantial part of the other three subscales. In interpreting the HRQoL scales, another methodological challenge is the phenomenon of response shift [51] . As patients with prostate cancer gradually adapt to symptoms and side-effects, changes in general HRQoL might diminish over time. This effect might explain, apart from RP selection bias, the fact that HAROW patients report better global HRQoL than German men without prostate cancer. Possibly due to response shift or a lack of specificity of functional HRQoL scales, the observed changes in HRQoL are small. They do not reach thresholds for clinical meaningfulness such as a change of at least 10 units in either domain or item score [52] or a difference that exceeds half of a standard deviation of the baseline values [53] . Another limitation is the fact that HRQoL is mainly influenced by urinary incontinence, which we did not control for in our analyses. Future analyses will have to examine the moderating or mediating role of urinary incontinence symptoms in the relationship between communication and HRQoL. Another important determinant of HRQoL is age; older men have lower HRQoL scores in many domains [32, 54] .
There are several aspects that strengthen the internal and external validity of our present work. We conducted a prospective study with a large and homogenous sample of patients undergoing the same treatment regimen. Due to the large sample size, the observation period with seven time points, and the nested structure of our data, we were able to apply advanced statistical modelling, i.e. multilevel analysis, to examine the associations between psychosocial care and HRQoL prospectively. According to our assumptions, we found significant associations between psychosocial care by physicians and HRQoL.
